Search

Search bills, members, committees and pages...

REBECCA MANDELL

16 federal lobbying filings, 2023 to 2026.

REBECCA MANDELL is a registered lobbyist named on 16 federal lobbying filings, 2023 to 2026.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

2 they have filed under, by filings.

RegistrantFilingsReported
TAKEDA PHARMACEUTICALS AMERICA, INC.11
ORGANON & CO.5

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262$2M
20255$5.5M
20245$3.2M
20234$1.5M

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
MMMMedicare/Medicaid16
DEFDefense11
HCRHealth Issues11
TRDTrade (domestic/foreign)11
BUDBudget/Appropriations10
TAXTaxation/Internal Revenue Code10

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.7
S. 832EPIC Act of 20257
H.R. 946ORPHAN Cures Act6
H.R. 4229To amend the Impoundment Control Act of 1974 to require prior approval from Congress before the Comptroller G…4
H.R. 1476PLASMA Act3
H.R. 2214DRUG Act3
S. 694PLASMA Act3
H.R. 2528Association Health Plans Act1

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2026 second_quarter$610KJul 20, 2026
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2026 first_quarter$1.4MApr 20, 2026
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2025 fourth_quarter$590KJan 20, 2026
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2025 third_quarter$1.4MOct 20, 2025
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2025 second_quarter$1.6MAug 26, 2025
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2025 second_quarter$1.5MJul 21, 2025
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2025 first_quarter$490KApr 22, 2025
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2024 fourth_quarter$390KApr 18, 2025
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2024 fourth_quarter$380KJan 21, 2025
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2024 third_quarter$970KOct 18, 2024
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2024 second_quarter$1.1MJul 22, 2024
ORGANON & CO.ORGANON & CO.2024 first_quarter$370KApr 22, 2024
ORGANON & CO.ORGANON & CO.2023 fourth_quarter$500KJan 22, 2024
ORGANON & CO.ORGANON & CO.2023 third_quarter$260KOct 20, 2023
ORGANON & CO.ORGANON & CO.2023 second_quarter$390KJul 20, 2023
ORGANON & CO.ORGANON & CO.2023 first_quarter$320KApr 20, 2023